Commonly known as “Quaaludes,” methaqualone
(1) is a sedative–hypnotic medication, with effects
resembling barbiturates and other downers, that exerts its effects
through modulation of γ-aminobutyric acid type A receptors (GABAAR). Following the discovery of the sedative and euphoric effects
of methaqualone (1), it was quickly adopted by pharmaceutical
companies and promoted by clinicians around the world as a “safe”
sleeping pill option, and for a period it was available over the counter.
The popularity of methaqualone (1) soared worldwide,
and many people began to use it recreationally for its sedative–hypnotic-like
psychoactive effects. Not long after its introduction, many individuals
began to misuse the drug leading to overdoses and drug dependence
which brought to light methaqualone’s (1) addictive
nature. In this review, the background, synthesis, pharmacology, metabolism,
and pharmacokinetics of methaqualone (1) will be covered
along with its discovery, history, and the derivatives that are currently
available around the world through manufacture in clandestine laboratories.